Chitosan-carboxymethyl tamarind kernel powder interpolymer complexation: Investigations for colon drug delivery

Scientia Pharmaceutica

Volumn 78, Issue 1, 2010, Pages 57-78

  Kaur, Gurpreet ^a   Jain, Subheet ^a   Tiwary, Ashok K ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

Budesonide; Colon release; Interpolymer complexation; Microbially triggered system; Polysaccharide based colon delivery

Indexed keywords

BUDESONIDE; CARBOXYL GROUP; CARBOXYMETHYL TAMARIND KERNEL POWDER; CHITOSAN; EUDRAGIT; HERBACEOUS AGENT; METHYL GROUP; MICROCRYSTALLINE CELLULOSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COMPLEX FORMATION; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SCREENING; DRUG STABILITY; FEMALE; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; INFRARED SPECTROSCOPY; INTERPOLYMER COMPLEXATION; IRRITABLE COLON; MALE; NONHUMAN; POLYMER PRODUCTION; RAT; STOMACH PH; TABLET PROPERTY; TAMARIND; ULCERATIVE COLITIS; VISCOSITY;

EID: 77749292285     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0908-10     Document Type: Article

References (28)

1. Ibekwe VC, Fadda HM, Parsons GE, Basit AW. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery. Int J Pharm. 2006; 308: 52-60. doi:10.1016/j.ijpharm. 2005.10.038
2. Pozzi F, Furlani P, Gazzaniga A, Davis SS, Wilding IR. The time clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J Control Rel. 1994; 31: 99-108. doi:10.1016/0168- 3659(94)90255-0
3. Rubinstein A. Colonic drug delivery Drug Dis. Today: Tech. 2005; 2: 33-37 doi:10.1016/j.ddtec.2005.05.021
4. Gliko-Kabir I, Yagen B, Baluom M, Rubinstein A. Phosphated crosslinked guar for colon-specific drug delivery II. In vitro and in vivo evaluation in the rat. J Control Rel. 2000; 63: 129-134. doi:10.1016/S0168-3659(99)00180-7
5. Du J, Dai J, Liu J, Dankovich T. Novel pH-sensitive polyelectrolyte carboxymethyl Konjac glucomannan-chitosan beads as drug carriers. React Funct Poly. 2006; 66: 1055-1061. doi:10.1016/j.reactfunctpolym.2006.01.014
6. Ko JA, Park HJ, Hwang Sj, Park JB, Lee JS. Preparation and characterization of chitosan microparticles intended for controlled drug delivery: Int J Pharm. 2002; 249: 165-174. doi:10.1016/S0378-5173(02)00487-8
7. Anal AK, Stevens, WF. Chitosan-alginate multilayer beads for controlled release of ampicillin. Int J Pharm. 2005; 290: 45-54. doi:10.1016/j.ijpharm. 2004.11.015
8. Xu Y, Zhan C, Fan L, Wang L, Zheng H. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system. Int J Pharm. 2007; 336: 329-337. doi:10.1016/j.ijpharm.2006.12.019
9. Rao PS, Beri RM Acetylation of tamarind seed jellose. Proc Math Sci. 1955; 42: 199-203. doi:10.1007/BF03053508
10. Prabhanjan H. Studies on modified tamarind kernel powder. Part I: Preparation and physicochemical properties of sodium salt of carboxymethyl derivatives. Starch/Stärke, 1989; 41: 409-414. doi:10.1002/star.19890411102
11. Friend DR. New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Del Rev. 2005; 57: 247-265. doi:10.1016/j.addr.2004.08.011
12. Green JW. In: Whistler RL. Methods in Carbohydrate Chemistry. New York, Academic Press, 1963; 3: 107.
13. Moustafine RI, Zaharov IM, Kemenova VA. Physicochemical characterization and drug release properties of Eudragit E PO/Eudragit L 100-55 interpolyelectrolyte complexes. Eur J Pharm Biopharm. 2006; 63: 26-36. doi:10.1016/j.ejpb.2005.10.005
14. Kemp W. Infrared Spectroscopy. In: Organic Spectroscopy. St. Martin's Press, New York, 1991: 60-71.
15. Berger J, Reist M, Felt O, Gurny R. Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur J Pharm Biopharm. 2000; 57: 35-52. doi:10.1016/S0939-6411(03) 00160-7
16. Prabhanjan H, Ali Z. Studies on rheological properties of tamarind kernel powder, its derivatives and their blends with maize starch. Carbohydr Polym. 1995; 28; 245-253. doi:10.1016/0144-8617(95)00106-9
17. United States Pharmacopeia. US Pharmacopeial convention, Rockville, MD, 2007:30, NF 25.
18. Li-Fang F, Wei, H Yong-Zhen C, Bai X, Qing D, Feng W, Min Q, De-Ying C. Studies on chitosan/Kollicoat SR30D film coated tablets for colonic drug delivery. Int J Pharm. 2009; 375: 8-15. doi:10.1016/j.ijpharm.2009.03.023
19. Tavakol M, Vasheghani-Farahani E, Doltabadi-Farhani T, Hashemi-Najafabadi S. Sulfasalazine release from alginate-N,O-carboxymethyl chitosan gel beads coated by chitosan. Carbohydr Polym. 2009; 77: 326-330. doi:10.1016/j.carbpol. 2009.01.005
20. Prasad YV, Krishnaiah YSR, Satyanarayana S. In vitro evaluation of guar gum as carrier for colon specific drug delivery. J Control Rel. 1998; 51: 281-287. doi:10.1016/S0168-3659(97)00181-8
21. Trimukhe KD, Bachate S, Gokhale DV, Varma AJ. Metal complexes of crosslinked chitosans Part II. An investigation of their hydrolysis to chitooligosaccharides using chitosanase. Int J Biol Macromol. 2007; 41: 491-496. doi:10.1016/j.ijbiomac.2007.06.009
22. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers Int J Pharm. 1983; 15: 25-35. doi:10.1016/0378-5173(83)90064-9
23. Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-fickian release from nonswellable devices in the form of slabs, spheres, cylinders or discs. J Control Rel. 1987; 5: 23-36. doi:10.1016/0168-3659(87)90034-4
24. Singh B, Sharma N, Chauhan N. Synthesis, characterization and swelling studies of pH responsive psyllium and methacrylamide based hydrogels for the use in colon specific drug delivery. Carbohydr Polym. 2007; 69: 631-642. doi:10.1016/j.carbpol.2007.01.020
25. Goyal P, Kumar V, Sharma P. Carboxymethylation of tamarind kernel powder. Carbohydr Polym. 2007; 69: 251-255. doi:10.1016/j.carbpol.2006.10.001
26. Rodríguez M, Vila-Jato J, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Rel. 1998; 55: 67-77. doi:10.1016/S0168- 3659(98)00029-7
27. Gupta M, Bhargava H. Development and validation of a high-performance liquid chromatographic method for the analysis of budesonide. J Pharm Biomed Anal. 2006; 40: 423-428. doi:10.1016/j.jpba.2005.06.038
28. Tozaki H, Odoriba T, Okada N, Fujita T, Terabe A, Suzuki T, Okabe S, Muranishi S, Yamamoto A. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats. J Control Rel. 2002; 82: 51-61. doi:10.1016/S0168-3659(02)00084-6